Finance

Lists
DVAI34:BVMF
Davita Inc BDR
893,56 R$
0,00%
(0,00) 1D
9 հոկ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DVAI34...
Open
893,56 R$
High
893,56 R$
Low
893,56 R$
Mkt. cap
11,60 մլրդ
Avg. vol.
7,00
Volume
1,00
52-wk high
1 253,26 R$
52-wk low
546,63 R$
Shares outstanding
63,80 մլն
No. of employees
78 հզր
Open
893,56 R$
High
893,56 R$
Low
893,56 R$
Mkt. cap
11,60 մլրդ
Avg. vol.
7,00
Volume
1,00
52-wk high
1 253,26 R$
52-wk low
546,63 R$
Shares outstanding
63,80 մլն
No. of employees
78 հզր
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc BDR
CEOJavier J. Rodriguez
Employees78 հզր
Founded1992
HeadquartersԴենվեր, Կոլորադո, Միացյալ Նահանգներ
SectorHealth care provider
Websitedavita.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,42 մլրդ
3,62 մլրդ
3,42 մլրդ
3,55 մլրդ
Cost of goods sold
2,33 մլրդ
2,41 մլրդ
2,34 մլրդ
2,39 մլրդ
Cost of revenue
2,33 մլրդ
2,41 մլրդ
2,34 մլրդ
2,39 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,67 մլն
472,36 մլն
421,91 մլն
423,46 մլն
Operating expense
580,16 մլն
659,06 մլն
599,74 մլն
591,27 մլն
Total operating expenses
2,91 մլրդ
3,07 մլրդ
2,94 մլրդ
2,98 մլրդ
Operating income
507,30 մլն
551,20 մլն
473,55 մլն
570,82 մլն
Other non operating income
-17,26 մլն
-21,03 մլն
639,00 հզր
4,47 մլն
EBT including unusual items
308,80 մլն
382,76 մլն
341,23 մլն
435,01 մլն
EBT excluding unusual items
351,55 մլն
391,79 մլն
341,23 մլն
437,04 մլն
Income tax expense
68,55 մլն
76,73 մլն
66,20 մլն
91,79 մլն
Effective tax rate
22,20%
20,05%
19,40%
21,10%
Other operating expenses
-
-
-
-
Net income
150,33 մլն
234,22 մլն
197,53 մլն
265,40 մլն
Net profit margin
4,40%
6,47%
5,78%
7,47%
Earnings per share
2,51
3,40
2,87
4,02
Interest and investment income
-
-
-
-
Interest expense
-148,66 մլն
-148,25 մլն
-141,30 մլն
-146,42 մլն
Net interest expenses
-148,66 մլն
-148,25 մլն
-141,30 մլն
-146,42 մլն
Depreciation and amortization charges
177,49 մլն
186,70 մլն
177,83 մլն
167,81 մլն
EBITDA
684,80 մլն
737,91 մլն
651,38 մլն
738,62 մլն
Gain or loss from assets sale
-
-17,55 մլն
-
-
AI content may include mistakes. Learn more
Google Apps